Prostate Cancer
Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE).
October 18, 2023
Radioligand Therapy With 177Lu-PSMA-I&T in Patients With Metastatic Prostate Cancer: Oncological Outcomes and Toxicity Profile.
October 18, 2023
Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer.
October 18, 2023
RAGE as a Novel Biomarker for Prostate Cancer: A Systematic Review and Meta-Analysis.
October 17, 2023
Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.
October 17, 2023
Prostate cancer image guided radiotherapy: Why the commotion over rectal volume and motion?
October 17, 2023
Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer.
October 17, 2023
Concurrent targeting of HDAC and PI3K to overcome phenotypic heterogeneity of castration-resistant and neuroendocrine prostate cancers.
October 16, 2023
Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews.
October 16, 2023
177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior 223Ra (RALU Study).
October 16, 2023